SCHEMBL4929079

SCHEMBL4929079

N#Cc1ccc(-c2cc[c]cc2C(N)=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.49
PARP1 P09874 3/20 0.45
PARP2 Q9UGN5 2/20 0.45
IRAK4 Q9NWZ3 1/20 0.42
PARP15 Q460N3 1/20 0.41
PARP10 Q53GL7 1/20 0.41
GRM2 Q14416 1/20 0.40
SCN9A Q15858 2/20 0.39
BCAT2 O15382 1/20 0.39
MMP3 P08254 1/20 0.38
MYC P01106 1/20 0.38
MAPK8 P45983 1/20 0.37
MAP4K4 O95819 1/20 0.37
MMP2 P08253 1/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
CSF1R P07333 1/20 0.36
MAP2 P11137 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3870677 0.81 CASP1 (0.46) CASP1PARP1BCAT2MAP4K4
SCHEMBL4924163 0.81 IKBKB (0.43) IRAK4GRM2SCN9ABCAT2MAPK8
SCHEMBL2637648 0.80 BCAT2 (0.61) CASP1PARP1BCAT2
SCHEMBL28045856 0.79 BCAT2 (0.65) CASP1PARP1PARP2IRAK4PARP15
SCHEMBL2744893 0.78 SMN1; SMN2 (0.50) CASP1PARP1PARP2PARP10GRM2
SCHEMBL3119391 0.77 CASP1 (0.48) CASP1PARP1SCN9ABCAT2MAP4K4
SCHEMBL28203104 0.75 CASP1 (0.52) CASP1PARP1PARP2IRAK4PARP15
SCHEMBL3225405 0.75 SMN1; SMN2 (0.50) PARP1CA1CA2CA12CA9
SCHEMBL3343827 0.73 BCAT2 (0.36) PARP1PARP2BCAT2MAPK8MAP4K4
SCHEMBL13518851 0.73 CASP1 (0.36) CASP1PARP1PARP2PARP15PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
EP-1765814-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2007-03-28 EP disclosed
WO-2006003096-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists GLP1R, GIPR, GCGR CASP1 494/4885PARP1 2877/4885PARP2 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.